Scale -

  • Revenue is 16983 Rs Cr; Annual Growth is 27 %; Continuous Growth over 3 years; in Top Quartile
  • Ebitda is 5033 Rs Cr; Annual Growth is 104 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • PBT is 643 Rs Cr; Annual Growth is 42 %; in Top Quartile
  • PAT is 1362 Rs Cr; Annual Growth is 30 %; Continuous Growth over 3 years
  • Quarterly Profit is 483 Rs Cr; in Top Quartile

Profitability -

  • PBDIT Margin is 29.63 %; Annual Growth is 60 %; Continuous Growth over 3 years; 5 Year CAGR is 10 %
  • PAT Margin is 8.01 %; Continuous Growth over 3 years; in Bottom Quartile
  • Quarterly Ebitda Margin is 20 %; Continuous Decline over 3 Quarters

Return -

  • ROCE is 32.95 %; Annual Growth is 68 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 20 %
  • ROA is 6.84 %; Continuous Growth over 3 years; in Bottom Quartile
  • ROE is 12.95 %; Continuous Growth over 3 years
  • Asset Turnover is 94 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 22 %

Efficiency -

  • Operating cash flow is 3445 Rs Cr; Annual Growth is 516 %; in Top Quartile; 5 Year CAGR is 33 %
  • Current Ratio is 1.77; Continuous Growth over 3 years
  • Quick Ratio is 1.23; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 5.26; Continuous Growth over 3 years; 5 Year CAGR is 30 %

Solvancy -

  • Debt/Equity is 0; Annual Decline is -100 %; in Bottom Quartile
  • Long term Debt is 0 Rs Cr; Annual Decline is -100 %
  • Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile

Quality -

  • Operating cashflow/ebitda is 68 %; Annual Growth is 304 %
  • Operating cashflow/PAT is 253 %; Annual Growth is 420 %; in Top Quartile; 5 Year CAGR is 23 %
  • Exceptional Items/PBT is -114 %; Annual Decline is -329 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is -5 %; Annual Decline is -152 %; Continuous Decline over 3 years; in Bottom Quartile
  • Current Tax/PAT is 50 %; Annual Growth is 36 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Glenmark moves distribution hub from NJ to Pennsylvania
Read More
  • Past/current
Namita Shah Elevated to Senior Vice President – Global Portfolio at Glenmark Pharmaceuticals
Read More
  • Past/current
Glenmark Pharmaceuticals Inaugurates U.S. Distribution Center in Allentown
Read More
  • Past/current
Trade Spotlight: How should you trade Chennai Petroleum, Sansera Engineering, Zydus Lifesciences, Indian...
Read More
  • Past/current
Another pharmaceutical company comes to Lehigh Valley. Take a look inside its new hub
Read More
  • Past/current
Glenmark Pharmaceuticals
Read More
  • Past/current
GLENMARK Stock Price and Chart — NSE:GLENMARK
Read More
  • Past/current